Abnormalities in FHR-5 have been shown to be associated with C3 glomerulopathy (C3G), a complement-mediated kidney disease with phenotypic similarities to IgAN.26, 27 In addition, FHR-5 is associated with fH deregulation in vitro.19 The gene discussed is FH; the disease is complement 3 glomerulopathy.